Evome Medical Technologies Inc.

LNDZF · OTC
Analyze with AI
12/31/2023
2/28/2022
2/28/2021
2/29/2020
Operating Activities
Net Income-$16-$4-$3-$2
Dep. & Amort.$2$1$1$0
Deferred Tax$0-$0-$0$0
Stock-Based Comp.$1$1$1$0
Change in WC-$1-$0$1$1
Other Non-Cash$12-$1-$1$0
Operating Cash Flow-$1-$4-$1-$0
Investing Activities
PP&E Inv.-$0-$0-$0$0
Net Acquisitions-$1-$5-$5$0
Inv. Purchases$0$0-$0-$1
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$5$0
Investing Cash Flow-$2-$5$0-$1
Financing Activities
Debt Repay.$1-$0$0$0
Stock Issued$0$4$4$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0$5$0
Financing Cash Flow$1$4$5$0
Forex Effect$1-$0-$0$0
Net Chg. in Cash-$1-$4$4-$1
Supplemental Information
Beg. Cash$2$13$8$9
End Cash$1$8$13$8
Free Cash Flow-$1-$4-$1-$0